15 Juin 2020.
Download the press release /Télécharger le communiqué
October, 2024. At the 36th ENA - EORTC - AACR symposium, Firas Bassissi, XENOTHERA CSO, presented highly promising results in pancreatic cancer.
August 24. Treatment with its antibody directed against tumor lymphocytes offers new hope for patients with PTCL
June, 2024. During its participation in ASCO, XENOTHERA….
